• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异源 Sarbecovirus 受体结合结构域作为 SARS-CoV-2 受体结合基序呈现的支架。

Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation.

机构信息

Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts 02139, United States.

Department of Microbiology, Harvard Medical School, Boston, Massachusetts 02115, United States.

出版信息

ACS Infect Dis. 2024 Feb 9;10(2):553-561. doi: 10.1021/acsinfecdis.3c00483. Epub 2024 Jan 28.

DOI:10.1021/acsinfecdis.3c00483
PMID:38281136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10862550/
Abstract

Structure-guided rational immunogen design can generate optimized immunogens that elicit a desired humoral response. Design strategies often center on targeting conserved sites on viral glycoproteins that will ultimately confer potent neutralization. For SARS-CoV-2 (SARS-2), the surface-exposed spike glycoprotein includes a broadly conserved portion, the receptor binding motif (RBM), that is required to engage the host cellular receptor, ACE2. Expanding humoral responses to this site may result in a more potent neutralizing antibody response against diverse sarbecoviruses. Here, we used a "resurfacing" approach and iterative design cycles to graft the SARS-2 RBM onto heterologous sarbecovirus scaffolds. The scaffolds were selected to vary the antigenic distance relative to SARS-2 to potentially focus responses to RBM. Multimerized versions of these immunogens elicited broad neutralization against sarbecoviruses in the context of preexisting SARS-2 immunity. These validated engineering approaches can help inform future immunogen design efforts for sarbecoviruses and are generally applicable to other viruses.

摘要

结构导向的合理免疫原设计可以产生优化的免疫原,引发所需的体液免疫反应。设计策略通常集中在针对病毒糖蛋白上保守的靶位,这些靶位最终将赋予强大的中和能力。对于 SARS-CoV-2(SARS-2),表面暴露的刺突糖蛋白包括一个广泛保守的部分,即受体结合基序(RBM),这是与宿主细胞受体 ACE2 结合所必需的。扩大对该部位的体液反应可能会导致针对多种沙贝科病毒产生更有效的中和抗体反应。在这里,我们使用了“表面重排”方法和迭代设计循环,将 SARS-2 的 RBM 嫁接到异源沙贝科病毒支架上。选择这些支架来改变相对于 SARS-2 的抗原距离,以潜在地将反应集中在 RBM 上。这些免疫原的多聚体版本在预先存在的 SARS-2 免疫的背景下引发了针对沙贝科病毒的广泛中和反应。这些经过验证的工程方法可以为沙贝科病毒的未来免疫原设计工作提供信息,并普遍适用于其他病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/d3b4d8e763d5/id3c00483_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/6fbc9a9364aa/id3c00483_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/4fbc91540b01/id3c00483_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/e7141e504a48/id3c00483_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/7113798edc6c/id3c00483_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/d3b4d8e763d5/id3c00483_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/6fbc9a9364aa/id3c00483_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/4fbc91540b01/id3c00483_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/e7141e504a48/id3c00483_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/7113798edc6c/id3c00483_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/10862550/d3b4d8e763d5/id3c00483_0005.jpg

相似文献

1
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation.异源 Sarbecovirus 受体结合结构域作为 SARS-CoV-2 受体结合基序呈现的支架。
ACS Infect Dis. 2024 Feb 9;10(2):553-561. doi: 10.1021/acsinfecdis.3c00483. Epub 2024 Jan 28.
2
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation.异源沙贝病毒受体结合域作为展示新冠病毒受体结合基序的支架
bioRxiv. 2023 Aug 22:2023.08.21.554179. doi: 10.1101/2023.08.21.554179.
3
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting.理性设计的免疫原可在 S 蛋白印迹后实现免疫聚焦。
Cell Rep. 2022 Mar 22;38(12):110561. doi: 10.1016/j.celrep.2022.110561. Epub 2022 Mar 7.
4
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif.工程化受体结合域免疫原可在受体结合基序之外引发泛沙贝病毒中和抗体。
bioRxiv. 2021 Jun 29:2020.12.07.415216. doi: 10.1101/2020.12.07.415216.
5
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif.合理设计的免疫原可使免疫聚焦于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合基序。
bioRxiv. 2021 Jul 9:2021.03.15.435440. doi: 10.1101/2021.03.15.435440.
6
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.靶向 Spike 受体结合域类五隐匿表位的具有泛沙贝科病毒活性的抗体。
J Virol. 2023 Jul 27;97(7):e0159622. doi: 10.1128/jvi.01596-22. Epub 2023 Jul 3.
7
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.通过计算设计和合成文库筛选获得广谱沙贝科病毒中和抗体。
J Virol. 2023 Jul 27;97(7):e0061023. doi: 10.1128/jvi.00610-23. Epub 2023 Jun 27.
8
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.设计一种针对细胞受体和病毒融合蛋白的双功能泛沙贝科病毒进入抑制剂。
J Virol. 2023 Aug 31;97(8):e0019223. doi: 10.1128/jvi.00192-23. Epub 2023 Aug 14.
9
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.用多种沙贝科病毒受体结合域进行免疫接种会产生针对脆弱性保守位点的 SARS-CoV-2 中和抗体。
Immunity. 2021 Dec 14;54(12):2908-2921.e6. doi: 10.1016/j.immuni.2021.10.019. Epub 2021 Oct 29.
10
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents.从 SARS 康复者中合理鉴定有效的、广谱的沙贝科病毒中和抗体鸡尾酒。
Cell Rep. 2022 Dec 20;41(12):111845. doi: 10.1016/j.celrep.2022.111845. Epub 2022 Dec 1.

本文引用的文献

1
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds.通过在非胸腺依赖型 DNA 折纸支架上展示多价抗原来增强抗体反应。
Nat Commun. 2024 Jan 30;15(1):795. doi: 10.1038/s41467-024-44869-0.
2
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design.针对多个供体的交叉反应性 SARS-CoV-2 表位可用于免疫原设计。
Cell Rep Med. 2022 Dec 20;3(12):100834. doi: 10.1016/j.xcrm.2022.100834. Epub 2022 Nov 15.
3
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
嵌合 RBD 纳米颗粒诱导产生的中和单克隆抗体结合保守的沙贝科病毒表位。
Immunity. 2022 Dec 13;55(12):2419-2435.e10. doi: 10.1016/j.immuni.2022.10.019. Epub 2022 Oct 27.
4
An epitope-enriched immunogen expands responses to a conserved viral site.一种富含表位的免疫原可增强对保守病毒位点的反应。
Cell Rep. 2022 Nov 8;41(6):111628. doi: 10.1016/j.celrep.2022.111628.
5
Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization.在预先存在的免疫背景下,针对 SARS-CoV-2 刺突蛋白和受体结合域的体液免疫反应赋予了广泛的沙贝科病毒中和作用。
Front Immunol. 2022 Aug 4;13:902260. doi: 10.3389/fimmu.2022.902260. eCollection 2022.
6
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting.理性设计的免疫原可在 S 蛋白印迹后实现免疫聚焦。
Cell Rep. 2022 Mar 22;38(12):110561. doi: 10.1016/j.celrep.2022.110561. Epub 2022 Mar 7.
7
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.人类 SARS-CoV-2 感染和接种疫苗中的免疫印迹、变体识别广度和生发中心反应。
Cell. 2022 Mar 17;185(6):1025-1040.e14. doi: 10.1016/j.cell.2022.01.018. Epub 2022 Jan 25.
8
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.广谱中和抗体可克服 SARS-CoV-2 奥密克戎抗原漂移。
Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.
9
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
10
Protein engineering strategies for rational immunogen design.用于合理免疫原设计的蛋白质工程策略。
NPJ Vaccines. 2021 Dec 17;6(1):154. doi: 10.1038/s41541-021-00417-1.